http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-203083-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07293d4b34d8372fb0775181fef9d23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
filingDate 1975-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fe55b7b362e3fa8f2c11e701d6d8fca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66c4333b93ccce26db84aaa2fbc1a38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdbc00857b2425017d3d5d9407a74fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d939ccea8e5fb41ed4485c8295c8af
publicationDate 1981-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CS-203083-B2
titleOfInvention Method of producing novel substituted 6-aryl-4h-o-triazolo/3,4-c/thieno/2,3-e/1,4-diazepines
abstract 1497527 Heterocyclic-fused 1,4-diazepine derivatives BOEHRINGER INGELHEIM GmbH 3 March 1975 [20 July 1974 24 Sept 1974 21 Dec 1974] 27236/77 Divided out of 1490269 Heading C2C The invention comprises compounds of Formula (I) wherein R 1 is H, Cl, Br or C 1-4 alkyl; R 2 is H, F, Cl, Br, NO 2 or CF 3 ; R 3 is Cl, Br, C 1-3 alkoxy or alkylthio, C 3-6 cycloalkyl or cycloalkenyl, or a 5- or 6-membered heterocyclic ring; and (except where R 3 is an S-containing ring) their acid addition salts. In examples, (I) are prepared by (a) heating the hydrazides (VII) (b) reacting the unacylated analogue of (VII) with R 1 -COCl, (c) reacting the 2-SH*, -SMe or -OEt (de-acylhydrazide) analogues of (VII) with R 1 CONHNH 2 , or (d) converting one substitutent (R 3 ) into another; (VII) are prepared by reacting the 2-SH compounds* with R 1 CONHNH 2 . Therapeutic compositions having anxiolytic, tensiolytic, muscle-relaxing and anticonvulsive activity, and which increase the intake of food in warm-blooded animals, comprise compounds of the above Formula (I). They may be administered orally, parenterally or rectally, and may contain other active compounds such as spasmolytics or beta-receptor blockers.
priorityDate 1974-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67706239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425172137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451412631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414876163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415973496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427870494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410522176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5231208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID468645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432123114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410441581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408128213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457797818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787

Total number of triples: 73.